Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Posch Florian |

Präsentationen bei wissenschaftlichen Veranstaltungen

Bezan, A; Posch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stoger, H; Gerger, A; Stotz, M Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J Clin Oncol 35, 2017 (suppl; abstr e16038). 2017; -ASCO (American Society of Clinical Oncology) Annual Meeting; June 2-6, 2017; McCormick Place, Chicago, IL. [Poster]

 

Leitner, L; Posch, F; Liegl-Atzwanger, B; Döller, C; Friesenbichler, J; Bergovec, M; Leithner, A; Szkandera, J; Evaluierung der Wirksamkeit von adjuvanter Bestrahlung auf Lokalrezidiv-Rate, Metastasierung und Gesamtüberleben von Patienten mit lokalisierten Weichteilsarkomen.
Abstractbook des DKOU 2017 in Berlin. 2017; -DKOU Berlin; OCT 24-27, 2017; Berlin, GERMANY. [Oral Communication]

 

Leitner, L; Posch, F; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Bergovec, M; Leithner, A; Szkandera, J; Lokalrezidiv-Rate, Metastasierung und Mortalität nach Resektion lokalisierter Weichteilsarkome in kurativer Intention: Ein multi-state Model.
Abstractbook des DKOU 2017 in Berlin. 2017; -DKOU Berlin; OCT 24-27, 2017; Berlin, GERMANY. [Oral Communication]

 

Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Gschwandtner, E; Strießnig, A; Swatek, P; Pichler, M; Posch, F; Stacher-Priehse, E; Anegg, U; Maier, A; Smolle-Juettner, FM HOW LONG SHOULD WE FOLLOW-UP PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER AFTER CURATIVE RESECTION? AN ANALYSIS OF 300 CASES USING FLEXIBLE PARAMETRIC MODELING OF TUMOR RECURRENCE AND MORTALITY RATES.
Book of Abstracts of the 25th European Conference on General Thoracic Surgery. 2017; 166-167.-25th European Conference on General Thoracic Surgery; MAY 28-31, 2017; Innsbruck, AUSTRIA. [Poster]
FullText

 

Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Gschwandtner, E; Strießnig, A; Swatek, P; Pichler, M; Posch, F; Stacher-Priehse, E; Anegg, U; Maier, A; Smolle-Juettner, FM PREDICTION OF CLINICAL OUTCOMES IN STAGE I NON-SMALL CELL LUNG CANCER AFTER CURATIVE SURGERY FOCUSING ON THE PREOPERATIVE GLASGOW PROGNOSTIC SCORE AND INFLAMMATORY BIOMARKERS.
Book of Abstracts of the 25th European Conference on General Thoracic Surgery. 2017; 214-215.-25th European Conference on General Thoracic Surgery; MAY 28-31, 2017; Innsbruck, AUSTRIA. [Oral Communication]
FullText

 

Posch, F; Therapie-assoziierte Komplikationen bei Patienten mit Hodenkrebs - Erfahrungen aus der GOTEKA Kohorte
OeGHO Frühjahrstagung; APR 6-8, 2017; Bregenz, Austria. 2017. [Oral Communication]
FullText

 

Posch, F; Silina, K; Petrausch, U; Leibl, S; Muendlein, A; Moch, H; Siebenhuener, AR; Pestalozzi, BC; Riedl, JM; Stotz, M; Szkandera, J; Stoeger, H; Pichler, M; Stupp, R; Schraml, P; Gerger, A; Winder, T; The maturation stage of tumoral tertiary lymphoid structures to predict recurrence risk in localized colorectal cancer.
Journal of Clinical Oncology. 2017; 35 (15_suppl): e15083-e15083.-American Society of Clinical Oncology (ASCO) Annual Meeting; JUN 2-6, 2017; Chicago, IL, USA.
FullText

 

Posch, Florian; Riedl, Jakob; Leitner, Lukas; Liegl-Atzwanger, Bernadette; Doeller, Carmen; Bezan, Angelika; Stotz, Michael; Pichler, Martin; Gerger, Armin; Bergovec, Marko; Stoeger, Herbert; Leithner, Andreas; Szkandera, Joanna Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study.
Proceedings of the 30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS), A-0001. 2017; 89--30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); APR 26-28, 2017; Budapest, HUNGARY. [Oral Communication]

 

Seles, M; Posch, F; Picherl, GP; Gary, T; Pummer, K; Zigeuner, R; Pichler, M, Hutterer, GC. Kleine Thrombozyten im peripheren Blut repräsentieren einen prognostisch ungünstigen Faktor bezogen auf das klinische Outcome in einer PatientInnen-Kohorte mit nicht-metastasiertem Nierenzellkarzinom
German Medical Science GMS Publishing House.doi: 10.3205/17oegu021. 2017; -43. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; MAY 16-18, 2017; Vienna, Austria. [Oral Communication]
FullText

 

Seles, M; Stojakovic, B; Hager, B; Posch, F; Bezan, A; Pummer, K; Zigeuner, R; Pichler, M; Hutterer GC. Evaluierung des prognostischen Einflusses der präoperativen Zahl eosinophiler Granulozyten im peripheren Blut auf das klinische Outcome in einer PatientInnen-Kohorte mit nicht-metastasiertem klarzellligen Nierenzellkarzinom
German Medical Science GMS Publishing House; 2017. Doc17oegu022. 2017; -43. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; MAY 16-18, 2017; Vienna, Austria. [Oral Communication]
FullText

 

Smolle, MA; Tunn, PU; Goldenitsch, E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A Why Should Unplanned Excisions Best Be Avoided In Soft-Tissue Sarcomas? Results Of A Multi-Centre Study Including 728 Patients.
Abstractbook of 18th EFORT. 2017; -18th EFORT Congress; MAY 31 - JUN 2, 2017; Vienna, AUSTRIA. [Oral Communication]

 

Smolle, MA; Tunn, PU; Goldentisch E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A Welche prognostische Bedeutung haben ungeplante Resektionen bei Weichteilsarkomen? Resultate einer multizentrischen, retrospektiven Studie mit 728 operativ versorgten Weichteilsarkom-Patienten.
Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU); OCT 24-27, 2017; Berlin, GERMANY. 2017. [Oral Communication]

 

Angelika Bezan, Florian Posch, Ferdinand Ploner, Thomas Bauernhofer, Martin Pichler, Joanna Szkandera, Georg C. Hutterer, Karl Pummer, Thomas Gary, Hellmut Samonigg, Joerg Beyer, Thomas Winder, Thomas Hermanns, Christian D. Fankhauser, Armin Gerger, Michael Stotz Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
ÖGHO; March 17-19, 2016; Wien. 2016. [Oral Communication]

 

Beyer-Westendorf, J; Kreutz, R; Posch, F; Ay, C The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts decline in renal function over time in patients with atrial fibrillation and chronic kidney disease
EUR HEART J. 2016; 37: 604-604.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY. [Oral Communication]
Web of Science

 

Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Gerger, A; Stotz, M; 23 Risk stratification for venous thromboembolism in patients with testicular germ cell tumours
European Urology Supplements. 2016; 15(3):E23--European Association of Urology (EAU) Annual Meeting; MAR 11-15, 2016; Munich, GERMANY. [Oral Communication]
FullText

 

Posch, F Statistics for Thrombo-Oncologists
ISTH SSC; MAY 25-28, 2016; Montpellier, FRANCE. 2016. [Oral Communication]

 

Posch, F; Therapierelevante Laborparameter in der Onkologie und deren Bedeutung
AHOP Frühjahrstagung; MAR 17-19, 2016; Vienna, Austria. 2016. [Oral Communication]
FullText

 

Posch, F; Therapie Krebs-assoziierter Thrombosen - "prime time" für NOAKs/DOAKs?
OeGHO Frühjahrstagung; MAR 17-19, 2016; Vienna, Austria. 2016. [Oral Communication]
FullText

 

Posch, F; Leitner, L; Liegl-Atzwanger, B; Wink, A; Stotz, M; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); Nov 9-12; Lisbon, PORTUGAL. [Oral Communication]

 

Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Friesenbichler, J; Gerger, A; Stoeger, H; Leithner, A; Szkandera, J Conditional survival of patients with soft tissue sarcoma (STS) after curative resection
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NOV 9-12; Lisbon, PORTUGAL. [Poster]

 

Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: A multi-state model
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NO 9-12; Lisbon, PORTUGAL. [Poster]

 

Posch, F; Liegl-Atzwanger, B; Thalhammer, M; Stotz, M; Bezan, A; Mrsic, E; Samonigg, H; Pichler, M; Gerger, A; Szkandera, J Local recurrence, distant metastasis, adjuvant imatinib, and long-term survival outcomes in patients with gastrointestinal-stroma-tumors (GIST) after curative surgery: A multi-state model
ÖGHO; MARCH, 17-19, 2016; WIEN. 2016. [Oral Communication]

 

Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. [Poster]
Web of Science FullText FullText_MUG

 

Silina, K; Petrausch, U; Posch, F; Leibl, S; Mundlein, A; Moch, H; Siebenhuner, A; Stupp, R; Riedl, J; Pestalozzi, BC; Schraml, P; Gerger, A; Winder, T Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer
ANN ONCOL. 2016; 27:
Web of Science FullText FullText_MUG

 

Smolle, MA; Goldenitsch, E; Machacek, F; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J THERAPY AND OUTCOME OF PATIENTS FOLLOWING UNPLANNED EXCISIONS IN SOFT TISSUE SARCOMA: A MULTI- CENTRE EXPERIENCE.
Abstracts of CTOS 2016; P2-P185. 2016; -CTOS 2016; NOV 9-12, 2016; Lisbon, PORTUGAL. [Poster]

 

Smolle, MA; Posch, F; Szkandera, J; Bergovec, M; Leithner, A Der Einfluss von ungeplanten Resektionen auf das Überleben von Patienten mit Weichteilsarkomen: Eine retrospektive Datenanalyse.
33. Jahrestagung Österreichische Gesellschaft für Orthopädie und Orthopädische Chirurgie; SEP 29 - OCT 1, 2016; Villach, AUSTRIA. 2016. [Oral Communication]

 

Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A Conditional survival of patients with soft tissue sarcoma (STS) after curative Resection.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Oral Communication]

 

Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: A multi-state model.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Oral Communication]

 

Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27:
Web of Science FullText FullText_MUG

 

Ay, C; Posch, F; Riedl, J; Koenigsbruegge, O; Quehenberger, P; Zielinski, C; Pabinger, I Prediction of Venous Thromboembolism in Patients with Cancer By the Activated Partial Thromboplastin Time: Results from the Vienna Cancer and Thrombosis Study.
Abstracts of the 57th ASH Annual Meeting. 2015; 126(23):653-653.-American Society of Hematology (ASH) Annual Meeting; DEC 5-8, 2015; Orlando, FL, USA. [Oral Communication]
FullText

 

Gebhart, J; Posch, F; Koder, S; Perkmann, T; Quehenberger, P; Zoghlami, C; Ay, C; Pabinger, I Increased mortality in patients with the lupus anticoagulant: the Vienna lupus anticoagulant and thrombosis study (LATS)
Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. 2015; 13(S2):11-12.-International Society of Thrombosis & Haemostasis (ISTH) Congress 2015; JUN 20-25, 2015; Toronto, CANADA. [Oral Communication]
FullText

 

Hell, L; Ay, C; Posch, F; Koder, S; Gebhart, J; Pabinger, I; Thaler, J Low microparticle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis.
Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. 2015; 13(S2):892--International Society of Thrombosis & Haemostasis (ISTH) Congress 2015; JUN 20-25, 2015; Toronto, CANADA. [Poster]
FullText

 

Posch, F Thromboembolierisiko unter Chemotherapie
Intensivkurs Angiologie; OCT 23-24, 2015; Dresden, GERMANY. 2015. [Oral Communication]
FullText

 

Posch, F Paraneoplastische und Katheter-assoziierte Thrombosen
Intensivkurs Angiologie; OCT 23-24, 2015; Dresden, GERMANY. 2015. [Oral Communication]
FullText

 

Posch, F; Gebhart, J; Rand, Jacob H.; de Laat, B; Koder, S; Quehenberger, P; Ay, C; Pabinger, I Thrombotic Events in Lupus Anticoagulant Positive Patients Prospectively Correlate with Clinical Risk Factors - the Vienna Lupus Anticoagulant and Thrombosis Study (LATS).
Abstracts of the 57th ASH Annual Meeting. 2015; 126(23):652-652.-American Society of Hematology (ASH) Annual Meeting; DEC 5-8, 2015; Orlando, FL, USA. [Oral Communication]
FullText

 

Posch, F; Gebhart, J; Wu, X; Koder, S; Ay, C; Rand, JH; Pabinger, I Annexin A5 Resistance Is Associated with Thrombotic Risk in Patients with the Lupus Anticoagulant: The Vienna Lupus Anticoagulant and Thrombosis Study (LATS).
Abstracts of the 57th ASH Annual Meeting. 2015; 126(23):3555-3555.-American Society of Hematology (ASH) Annual Meeting; DEC 5-8, 2015; Orlando, FL, USA. [Poster]
FullText

 

Posch, F; Koenigsbruegge, O; Zielinski, C; Pabinger, I; Ay, C A network meta-analysis comparing the efficacy and safety of anticoagulants for the treatment of venous thromboembolism in cancer patients.
Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015.. 2015; 133(S2):193--International Society of Thrombosis & Haemostasis (ISTH) Congress 2015; JUN 20-25, 2015; Toronto, CANADA. [Oral Communication]
FullText

 

Posch, F; Reitter, EM; Riedl, J; Pabinger, I; Ay, C Hypercoagulability, venous thromboembolism and death in patients with cancer: a multi-state model
Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. 2015; 13(S2):181--Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015; JUN 20-25, 2015; Toronto, CANADA. [Oral Communication]
FullText

 

Riedl, J; Preusser, M; Posch, F; Marosi, C; Birner, P; Thaler, J; Hainfellner, J; Pabinger, I; Ay, C Podoplanin expression and intravascular platelet aggregates: the missing link between cancer and thrombosis in primary malignant brain tumors
Journal of Thrombosis & Haemostasis (JTH) Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. 2015; 133(S2):232--International Society of Thrombosis & Haemostasis (ISTH) Congress 2015; JUN 20-25, 2015; Toronto, CANADA. [Oral Communication]
FullText

 

Posch, F; Ay, C; Kaider, A; Zielinski, C; Pabinger, I Estimating rates of venous thromboembolism in patients with cancer using the Kaplan-Meier and competing-risk approach: insights from the Vienna Cancer and Thrombosis Study.
Thrombosis Research, Volume 133, Supplement 2, Pages S1-S228.. 2014; 190-190.-7th International Conference on Thrombosis and Hemostasis Issues in Cancer; MAY 9-11, 2014; Bergamo, ITALY. [Poster]
FullText

 

Riedl, J; Kaider, A; Posch, F; Koder, S; Reitter, EM; Marosi, C; Zielinski, C; Pabinger, I; Ay, C; Association of soluble CD40 ligand and thrombospondin-1 with cancer-associated venous thromboembolism.
Thrombosis Research, Volume 133, Supplement 2, Pages S1-S228. 2014; 205-206.-7th International Conference on Thrombosis and Hemostasis Issues in Cancer; MAY 9-11, 2014; Bergamo, ITALY. [Poster]
FullText

 

© Meduni Graz Impressum